PureTech Health PLCLSE: PRTC

PureTech Health: Holding(s) in Company

· Issued by PureTech Health PLC via RNS

Summary by 6ix AI

Lansdowne Partners (UK) LLP notified PURETECH HEALTH PLC that an acquisition or disposal of voting rights took its holding across a reporting threshold, a percentage level at which major holdings must be disclosed, on October 29, 2026. On that date it held 4.967367% of the voting rights.

Key details

  • The position is 12,178,974 voting rights attached to shares, all held indirectly, meaning through another entity rather than in the holder's own name, with none held through financial instruments.
  • Lansdowne Partners International Limited controls Lansdowne Partners (UK) LLP, which holds the voting rights.
  • PURETECH HEALTH PLC was notified on October 30, 2026.

6ix AI wrote this summary from the release below and checked it against the release.

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BY2Z0H74

Issuer Name

PURETECH HEALTH PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Lansdowne Partners (UK) LLP

City of registered office (if applicable)

Country of registered office (if applicable)

GB

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

29-Oct-2026

6. Date on which Issuer notified

30-Oct-2026

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

4.967367

0.000000

4.967367

12178974

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BY2Z0H74

0

12178974

0.000000

4.967367

Sub Total 8.A

12178974

4.967367%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Lansdowne Partners International Limited

Lansdowne Partners (UK) LLP

4.967367

0.000000

4.967367%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

If date does not apply, explain below

11. Additional Information

12. Date of Completion

13. Place Of Completion

London

PureTech Health PLC on 6ix

Earlier from PureTech Health

All PureTech Health news releases